Skip to main content

Table 5 Survival of patients according to first line chemotherapy

From: An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents

  Median overall survival
  Time in months (95% CI)
Cisplatin + taxanes (N = 46) 14.2 (10.8-19.6)
Carboplatin + taxanes (N = 69) 10.5 (7.6-13.1)
Platinum without taxanes (N = 28) 11.2 (8.6-25.3)
Other chemotherapy (N = 48) 5.6 (4.3-8.1)
Clinical trials testing not approved regimens (N = 7) 5.7 (1.7 – NR)
  1. NR = Non Reached.
\